| Code | Description | Claims | Beneficiaries | Total Paid |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
559 |
434 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
46 |
38 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
458 |
340 |
$56.35 |
| G9500 |
Radiation exposure indices documented in final report for procedure using fluoroscopy |
565 |
430 |
$1.58 |
| G9562 |
Patients who had a follow-up evaluation conducted at least every three months during opioid therapy |
27 |
22 |
$0.90 |
| G9584 |
Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy |
27 |
22 |
$0.90 |
| 1006F |
|
44 |
36 |
$0.00 |
| 1036F |
|
15 |
12 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
37 |
31 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
27 |
22 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
24 |
21 |
$0.00 |
| G9578 |
Documentation of signed opioid treatment agreement at least once during opioid therapy |
27 |
22 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
26 |
21 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
14 |
12 |
$0.00 |